@endece.com
ENDECE developed NDC-1308 a novel therapeutic that has a unique mechanism-of-action for inducing remyelination AND inhibiting demyelination
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
ENDECE is a pioneering biopharmaceutical company based in Portland, OR, dedicated to shaping a healthier future for individuals grappling with severe and life-threatening illnesses. With a strong focus on addressing the needs of these individuals, ENDECE has developed a remarkable library of proprietary compounds. These compounds possess a unique ability to modify specific gene expression, ultimately restoring function and hope to those affected.
Comprised of esteemed scientific minds and industry leaders, the ENDECE team embarks on a journey to achieve significant regulatory and clinical milestones, greatly enhancing the quality of life for countless individuals. From the devastating realms of ARDS, COVID-19, Multiple Sclerosis, Alzheimer's Disease, Neuromyelitis Optica Spectrum Disorder, to Niemann-Pick disease type C and Osmotic Demyelination Syndrome, ENDECE confronts these challenges head-on. Stay connected with ENDECE through their Facebook page and be part of their mission to build a healthier future
Company Type
Privately Held
Company Size
2-10
Year Founded
2006
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories